Pilot Evaluation of a Stellate Ganglion Block for the Treatment of Hot Flashes
- To evaluate the impact of stellate ganglion blockade on hot flash scores.
- To evaluate the toxicity of stellate ganglion blockade.
OUTLINE: Patients undergo fluoroscopic-guided stellate ganglion blockade using bupivacaine
hydrochloride in week 1.
Patients complete a hot flash diary daily and a symptom experience diary weekly in weeks 1-7
and the Profile of Mood States questionnaire in weeks 1 and 7.
After completion of study treatment, patients are followed at 2 months and then monthly for
Primary Purpose: Supportive Care
Difference in hot flash activity between baseline and week 7
Charles L. Loprinzi, MD
United States: Federal Government
|Mayo Clinic||Rochester, Minnesota 55905|